• Citer

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries

par Body, Jean-Jacques ;Caraceni, Augusto;Adamo, Vincenzo;Hechmati, Guy;Gatta, Francesca;De Cock, Erwin;Tao, Sunning;Kritikou, Persefoni;Wimberger, Pauline;Mebis, Jeroen;Peeters, Michel ;Pedrazzoli, Paolo
Référence Supportive care in cancer, 25, 9, page (2823-2832)
Publication Publié, 2017-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries
Auteur:	Body, Jean-Jacques; Caraceni, Augusto; Adamo, Vincenzo; Hechmati, Guy; Gatta, Francesca; De Cock, Erwin; Tao, Sunning; Kritikou, Persefoni; Wimberger, Pauline; Mebis, Jeroen; Peeters, Michel; Pedrazzoli, Paolo
Informations sur la publication:	Supportive care in cancer, 25, 9, page (2823-2832)
Statut de publication:	Publié, 2017-09
Sujet CREF:	Cancérologie
Mots-clés:	Denosumab
	Metastatic bone disease
	Time and motion study
	Zoledronic acid
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0941-4355
	info:doi/10.1007/s00520-017-3697-5
	info:scp/85018520580